The eighth American college of chest physicians guidelines on venous thromboembolism prevention: Implications for hospital prophylaxis strategies

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 2, 2011, Pages 196-208

  Huo, Michael H ^b   Spyropoulos, Alex C ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

Guidelines; Performance measures; Prophylaxis; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIVITAMIN K; DALTEPARIN; DEXTRAN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LENALIDOMIDE; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PLACEBO; THALIDOMIDE; WARFARIN;

ACCREDITATION; ARTICLE; BLEEDING; CANCER HORMONE THERAPY; CANCER PATIENT; COMPRESSION GARMENT; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DRUG DOSE COMPARISON; DRUG INDICATION; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HOSPITAL CARE; HOSPITAL POLICY; HUMAN; INCIDENCE; LOW DRUG DOSE; LUNG EMBOLISM; MALIGNANT NEOPLASTIC DISEASE; MEDICAL FEE; MEDICAL SPECIALIST; MULTIPLE MYELOMA; PATIENT CARE; PATIENT SAFETY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; RISK REDUCTION; SURGICAL RISK; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; VENOUS THROMBOEMBOLISM;

EID: 79951724134     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0500-6     Document Type: Article

References (61)

1. WH Geerts D Bergqvist GF Pineo, et al. 2008 Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl 381S 453S 1:CAS:528:DC%2BD1cXptVKhsrg%3D 10.1378/chest.08-0656 18574271 (Pubitemid 351894916)
2. A Amin S Stemkowski J Lin G Yang 2007 Thromboprophylaxis rates in US medical centers, success or failure? J Thromb Haemost 5 1610 1616 1:STN:280:DC%2BD2svks1Gmug%3D%3D 10.1111/j.1538-7836.2007.02650.x 17663733 (Pubitemid 47091400)
3. AN Amin S Stemkowski J Lin G Yang 2008 Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis? Thromb Haemost 99 796 797 1:CAS:528:DC%2BD1cXlsF2gtLs%3D 18392346 (Pubitemid 351694244)
4. VF Tapson H Decousus M Pini, et al. 2007 Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism Chest 132 936 945 10.1378/chest.06-2993 17573514
5. AT Cohen VF Tapson JF Bergmann, et al. 2008 Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study Lancet 371 387 394 10.1016/S0140-6736(08) 60202-0 18242412 (Pubitemid 351173321)
6. AC Spyropoulos J Lin 2007 Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations J Manag Care Pharm 13 475 486 17672809 (Pubitemid 350193368)
7. DA MacDougall AL Feliu SJ Boccuzzi J Lin 2006 Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome Am J Health Syst Pharm 63 20 Suppl 6 S5 S15 10.2146/ajhp060388 17032933 (Pubitemid 44672124)
8. FA Anderson Jr M Zayaruzny JA Heit D Fidan AT Cohen 2007 Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism Am J Hematol 82 777 782 10.1002/ajh.20983 17626254 (Pubitemid 350194504)
9. AN Nicolaides HK Breddin J Fareed, et al. 2001 Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence Int Angiol 20 1 37 1:STN:280: DC%2BD3M3ktFKmtQ%3D%3D 10.1177/000331970105200101 11342993 (Pubitemid 32605650)
10. Agency for Healthcare Research and Quality (2001) Making health care safer: a critical analysis of patient safety practices. http://www.ahrq.gov/ clinic/ptsafety/pdf/ptsafety.pdf. Accessed 19 April 2010
11. SR Kahn A Panju W Geerts, et al. 2007 Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada Thromb Res 119 145 155 1:CAS:528:DC%2BD28Xht1CqtLrI 10.1016/j.thromres.2006.01. 011 16516275 (Pubitemid 44810862)
12. E Burleigh C Wang D Foster, et al. 2006 Thromboprophylaxis in medically ill patients at risk for venous thromboembolism Am J Health Syst Pharm 63 20 Suppl 6 S23 S29 10.2146/ajhp060390 17032931 (Pubitemid 44672126)
13. RJ Friedman AS Gallus FD Cushner G Fitzgerald FA Anderson Jr Global Orthopaedic Registry Investigators 2008 Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty Curr Med Res Opin 24 87 97 18028586 (Pubitemid 351160242)
14. GH Lyman AA Khorana A Falanga, et al. 2007 American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J Clin Oncol 25 5490 5505 1:CAS:528: DC%2BD1cXnvVChtA%3D%3D 10.1200/JCO.2007.14.1283 17968019 (Pubitemid 350232226)
15. R Tooher P Middleton C Pham, et al. 2005 A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals Ann Surg 241 397 415 10.1097/01.sla.0000154120.96169.99 15729062 (Pubitemid 40299716)
16. P Durieux R Nizard P Ravaud N Mounier E Lepage 2000 A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior JAMA 283 2816 2821 1:STN:280:DC%2BD3c3pvFWgsA%3D%3D 10.1001/jama.283.21.2816 10838650 (Pubitemid 30387826)
17. N Kucher S Koo R Quiroz, et al. 2005 Electronic alerts to prevent venous thromboembolism among hospitalized patients N Engl J Med 352 969 977 1:CAS:528:DC%2BD2MXit1Wks7o%3D 10.1056/NEJMoa041533 15758007 (Pubitemid 40349499)
18. D Mosen CG Elliott MJ Egger, et al. 2004 The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism Chest 125 1635 1641 10.1378/chest.125.5.1635 15136370 (Pubitemid 38648391)
19. JB Bauer DS Chun TA Karpinski 2008 Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital Am J Health Syst Pharm 65 1643 1647 10.2146/ajhp070595 18714111
20. Mahan CE, Hussein MA, Amin AN, Spyropoulos AC (2009) Venous thromboembolism pharmacy intervention management program. J Thromb Haemost 7(Suppl 2). (abstract OC-TH-016)
21. WH Geerts GF Pineo JA Heit, et al. 2004 Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 338S 400S 1:CAS:528:DC%2BD2cXptV2msbw%3D 10.1378/chest.126.3 15383478 (Pubitemid 39302602)
22. FA Spencer D Lessard C Emery G Reed RJ Goldberg 2007 Venous thromboembolism in the outpatient setting Arch Intern Med 167 1471 1475 10.1001/archinte.167.14.1471 17646600 (Pubitemid 47124177)
23. MM Samama AT Cohen JY Darmon, et al. 1999 A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 341 793 800 1:CAS:528:DyaK1MXmtlGjsrs%3D 10.1056/NEJM199909093411103 10477777 (Pubitemid 29420474)
24. A Leizorovicz AT Cohen AG Turpie, et al. 2004 Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 874 879 1:CAS:528:DC%2BD2cXmtlOqtb4%3D 10.1161/01.CIR.0000138928.83266.24 15289368 (Pubitemid 39096017)
25. AT Cohen BL Davidson AS Gallus, et al. 2006 Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial BMJ 332 325 329 1:CAS:528:DC%2BD28XitFSgsL0%3D 10.1136/bmj.38733.466748.7C 16439370 (Pubitemid 43253745)
26. CJ DeFrances MJ Hall 2007 2005 National Hospital Discharge Survey Adv Data 385 1 19 17691217
27. RD Hull GF Pineo 1999 Extended prophylaxis against venous thromboembolism following total hip and knee replacement Haemostasis 29 Suppl S1 23 31 1:CAS:528:DC%2BD3cXjs1Gnuw%3D%3D 10629401 (Pubitemid 30026738)
28. JW Eikelboom DJ Quinlan JD Douketis 2001 Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials Lancet 358 9 15 1:STN:280: DC%2BD3Mvgt1Gkug%3D%3D 10.1016/S0140-6736(00)05249-1 11454370 (Pubitemid 32709732)
29. RD Hull GF Pineo PD Stein, et al. 2001 Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review Ann Intern Med 135 858 869 1:CAS:528:DC%2BD3MXptVKks7o%3D 11712876 (Pubitemid 33070682)
30. MS Rasmussen LN Jorgensen P Wille-Jørgensen, et al. 2006 Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study J Thromb Haemost 4 2384 2390 1:CAS:528:DC%2BD28Xht1yjtbnJ 10.1111/j.1538-7836.2006.02153.x 16881934 (Pubitemid 44575433)
31. D Bergqvist G Agnelli AT Cohen, et al. 2002 Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer N Engl J Med 346 975 980 1:CAS:528:DC%2BD38XitlCit7g%3D 10.1056/NEJMoa012385 11919306 (Pubitemid 34983247)
32. BI Eriksson MR Lassen PENTasaccharide in HIp-FRActure Surgery Plus Investigators 2003 Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study Arch Intern Med 163 1337 1342 1:CAS:528:DC%2BD3sXltVSntrs%3D 10.1001/archinte.163.11.1337 12796070 (Pubitemid 36676199)
33. FJ Bottaro MC Elizondo C Doti, et al. 2008 Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis Thromb Haemost 99 1104 1111 1:CAS:528:DC%2BD1cXotVyjsLk%3D 18521515 (Pubitemid 351810493)
34. CS King AB Holley JL Jackson AF Shorr LK Moores 2007 Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: a metaanalysis Chest 131 507 516 1:CAS:528:DC%2BD2sXjtlWqt7o%3D 10.1378/chest.06-1861 17296655 (Pubitemid 46280413)
35. JA Caprini JI Arcelus JJ Reyna 2001 Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease Semin Hematol 38 2 Suppl 5 12 19 1:STN:280:DC%2BD38%2FitVGmtw%3D%3D 10.1016/S0037-1963(01)90094-0 11449339 (Pubitemid 32606834)
36. AA Khorana NM Kuderer E Culakova GH Lyman CW Francis 2008 Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 4902 4907 1:CAS:528:DC%2BD1cXmtlaiur8%3D 10.1182/blood-2007-10-116327 18216292
37. AC Spyropoulos 2009 Upper vs lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients J Thromb Haemost 7 1041 1042 1:STN:280:DC%2BD1MvjvFejtg%3D%3D 10.1111/j.1538-7836.2009.03351.x 19548912
38. Kuderer NM, Khorana AA, Francis CW et al. (2008) Venous thromboembolism risk model predicts early progression and overall mortality in cancer patients receiving chemotherapy. Blood 112. (abstract 172)
39. Spyropoulos AC, Anderson FA, FitzGerald G, Decousus H, Tapson V (2009) Venous thromboembolism risk factors in acutely ill hospitalized medical patients: findings from the improve registry. J Thromb Haemost 7(Suppl 2). (abstract OC-MO-052)
40. G Agnelli D Bergqvist AT Cohen AS Gallus M Gent PEGASUS investigators 2005 Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery Br J Surg 92 1212 1220 1:CAS:528:DC%2BD2MXhtF2qs73K 10.1002/bjs.5154 16175516 (Pubitemid 41475229)
41. AG Turpie KA Bauer JA Caprini, et al. 2007 Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for the prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison J Thromb Haemost 5 1854 1861 1:CAS:528:DC%2BD2sXhtFahtL3N 10.1111/j.1538-7836.2007.02657.x 17723125 (Pubitemid 47288942)
42. N Levitan A Dowlati SC Remick, et al. 1999 Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 285 291 1:STN:280:DyaK1MvivVymug%3D%3D 10.1097/00005792-199909000-00001 (Pubitemid 29439263)
43. D Mukherjee AO Lidor KM Chu SL Gearhart ER Haut DC Chang 2008 Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations J Gastrointest Surg 12 2015 2022 10.1007/s11605-008-0600-1 18668299
44. N Ruíz-Giménez C Suárez R González, et al. 2008 Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry Thromb Haemost 100 26 31 18612534 (Pubitemid 351952971)
45. Agnelli C, Gussoni G, Bianchini C, Verso M, Tonato M (2008) A randomized double-blind placebo-controlled study on nadroparin for prophylaxis of thromboembolic events in cancer patients receiving chemotherapy: the PROTECHT study. Blood 112. (abstract 6)
46. DM Weber C Chen R Niesvizky, et al. 2007 Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America N Engl J Med 357 2133 2142 1:CAS:528:DC%2BD2sXhtlGis7bM 10.1056/NEJMoa070596 18032763 (Pubitemid 350146108)
47. National Comprehensive Cancer Network (2006) NCCN clinical practice guidelines in oncology™. Venous thromboembolic disease, version 1. http://www.nccn.org/professionals/physician-gls/default.asp. Accessed 19 April 2010
48. US Department of Health and Human Services (2008) The surgeon general's call to action to prevent deep vein thrombosis and pulmonary embolism. http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action-on- dvt-2008.pdf. Accessed 19 April 2010
49. M Sobieraj-Teague JW Eikelboom J Hirsh 2010 How can we reduce disagreement among guidelines for venous thromboembolism prevention? J Thromb Haemost 8 4 675 677 1:STN:280:DC%2BC3c3mvVSktw%3D%3D 10.1111/j.1538-7836.2010. 03776.x 20096000
50. JW Eikelboom G Karthikeyan N Fagel J Hirsh 2009 American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest 135 513 520 10.1378/chest.08-2655 19201714
51. American Academy of orthopaedic surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty (2007) Adopted by the American Academy of Orthopaedic Surgeons Board of Directors. http://www.aaos.org/research/guidelines/PE-guideline.pdf. Accessed 19 April 2010
52. GH Guyatt AD Oxman R Kunz, et al. 2008 Going from evidence to recommendations BMJ 336 1049 1051 10.1136/bmj.39493.646875.AE 18467413
53. QualityNet. MedQIC. SCIP project information. http://www.medqic.org/dcs/ ContentServer?cid=1122904930422&pagename= Medqic%2FContent%2FParentShellTemplate&parentName=Topic&c=MQParents. Accessed 19 April 2010
54. National Quality Forum (2006) National Voluntary Consensus standards for prevention and care of venous thromboembolism: policy, preferred practices, and initial performance measures. Executive summary. http://www.qualityforum.org/ Publications/2006/12/National-Voluntary-Consensus-Standards-for-Prevention-and- Care-of-Venous-Thromboembolism-Policy,-Preferred-Practices,-and-Initial- Performance-Measures.aspx. Accessed 19 April 2010
55. The Joint Commission (2009) Performance measurement initiatives. Venous thromboembolism (VTE) core measurement set-Last Updated 4/2009. http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/ VTE.htm. Accessed 19 April 2010
56. Agency for Healthcare Research and Quality. Preventing Hospital-Acquired Venous Thromboembolism. A guide for effective quality improvement. http://www.ahrq.gov/qual/vtguide/. Accessed 19 April 2010
57. Centers for Medicare and Medicaid Services (2010) Reporting Hospital Quality Data for Annual Payment Update. http://www.cms.hhs.gov/ HospitalQualityInits/08-HospitalRHQDAPU.asp. Accessed 19 April 2010
58. The Leapfrog Group (2010) The Leapfrog Hospital Survey: what's new in the 2010 survey (version 5.2). https://leapfrog.medstat.com/pdf/final.doc. Accessed 19 April 2010
59. Centers for Medicare and Medicaid Services (2008) Physician groups earn performance payments for improving quality of care for patients with chronic illnesses. Press release August 2008. http://www.cms.hhs.gov/apps/media/press/ release.asp?Counter=3239&intNumPerPage=10&checkDate=&checkKey= &srchType=1&numDays=3500&srchOpt=0&srchData=&keywordType= All&chkNewsType=1%2C+2%2C+3%2C+4%2C+5&intPage=&showAll=&pYear= &year=&desc=false&cboOrder=date. Accessed 19 April 2010
60. Centers for Medicare and Medicaid Services (2008) Medicare and Medicaid move aggressively to encourage greater patient safety in hospitals and reduce never events. Press release July 2008. http://www.cms.hhs.gov/apps/media/press/ release.asp?Counter=3219&intNumPerPage=10&checkDate=&checkKey= &srchType=1&numDays=3500&srchOpt=0&srchData=&keywordType= All&chkNewsType=1%2C+2%2C+3%2C+4%2C+5&intPage=&showAll=&pYear= &year=&desc=false&cboOrder=date. Accessed 19 April 2010
61. V Vats EA Nutescu JC Theobald JE Wojtynek GT Schumock 2007 Survey of hospitals for guidelines, policies, and protocols for anticoagulants Am J Health Syst Pharm 64 1203 1208 10.2146/ajhp060264 17519463 (Pubitemid 46849311)